Decamethonium bromide NEW
| Price | $29 |
| Package | 500mg |
| Supply Ability: | 10g |
| Update Time: | 2026-04-21 |
Product Details
| Product Name: Decamethonium bromide | CAS No.: 541-22-0 |
| Purity: 99.90% | Supply Ability: 10g |
| Release date: 2026/04/21 |
Product Introduction
Bioactivity
| Name | Decamethonium bromide |
| Description | Decamethonium bromide (Syncurine) is a neuromuscular blocker and nicotinic AChR partial agonist. |
| In vivo | At the motor neuromuscular endplate, Decamethonium induces a depolarization that prevents the normal release of acetylcholine from presynaptic terminals from acting further, thereby preventing the nerve stimulus from affecting the muscle. During binding, Decamethonium actually activates (depolarizes) the motor endplate, but does not degrade itself, so the cell membrane remains depolarized and unresponsive to normal acetylcholine release. As a depolarizing muscle relaxant or neuromuscular blocker, Decamethonium is used in anesthesia to induce paralysis. It has a short duration of action similar to that of acetylcholine and acts as a partial agonist at nicotinic acetylcholine-like receptors. |
| Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year |
| Solubility Information | 10% DMSO+40% PEG300+5% Tween 80+45% Saline : 2 mg/mL (4.78 mM), Sonication is recommended. H2O : 77 mg/mL (184.08 mM), Sonication is recommended. DMSO : 65 mg/mL (155.39 mM), Sonication is recommended. Ethanol : 24 mg/mL (57.38 mM), Sonication is recommended. |
| Keywords | Nicotinic acetylcholine receptors | nAChR | Inhibitor | inhibit | Decamethonium bromide | Decamethonium | AChE |
| Inhibitors Related | Adiphenine hydrochloride | Uridine 5'-monophosphate disodium salt | Urethane | Hexamethonium Bromide | Ribavirin | Diethyltoluamide | Adenine | Mitotane | N,N-Dicyclohexylcarbodiimide | Dimethyl sulfoxide | Coumaran | Arecoline |
| Related Compound Libraries | Bioactive Compound Library | Pain-Related Compound Library | Anti-Neurodegenerative Disease Compound Library | Neuronal Signaling Compound Library | Membrane Protein-targeted Compound Library | ReFRAME Related Library | Drug Repurposing Compound Library | Inhibitor Library | NO PAINS Compound Library | FDA-Approved Drug Library | Bioactive Compounds Library Max | Ion Channel Targeted Library |
Company Profile Introduction
Target Molecule Corp. (TargetMol) is a global high-tech enterprise, headquartered in Boston, MA, specializing in chemical and biological research product and service to meet the research needs of global customers.
TargetMol has evolved into one of the biggest global compound library and small molecule suppliers and a customer based on 40+ countries. TargetMol offers over 80 types of compound libraries and a wide range of high-quality research chemicals including inhibitors, activator, natural compounds, peptides, inhibitory antibodies, and novel life-science kits, for laboratory and scientific use. Besides, virtual screening service is also available for customers who would like to conduct the computer-aided drug discovery.
You may like
Recommended supplier
| Product name | Price | Suppliers | Update time | |
|---|---|---|---|---|
| $29.00 |
VIP4Y
|
TargetMol Chemicals Inc.
|
2026-05-11 | |
| $45.00 |
VIP2Y
|
TargetMol Chemicals Inc.
|
2025-04-27 | |
| $9.80 |
VIP7Y
|
Career Henan Chemical Co
|
2020-01-10 |
United States- Since: 2011-01-07
- Address: 36 Washington Street, Wellesley Hill, MA
INQUIRY